1. Home
  2. VREX vs VOR Comparison

VREX vs VOR Comparison

Compare VREX & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Varex Imaging Corporation

VREX

Varex Imaging Corporation

HOLD

Current Price

$11.51

Market Cap

580.6M

Sector

Technology

ML Signal

HOLD

Logo Vor Biopharma Inc.

VOR

Vor Biopharma Inc.

HOLD

Current Price

$15.05

Market Cap

562.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VREX
VOR
Founded
2016
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
580.6M
562.6M
IPO Year
2016
2021

Fundamental Metrics

Financial Performance
Metric
VREX
VOR
Price
$11.51
$15.05
Analyst Decision
Strong Buy
Buy
Analyst Count
3
10
Target Price
$16.67
$64.78
AVG Volume (30 Days)
349.0K
664.4K
Earning Date
05-12-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
2.86
EPS
0.05
N/A
Revenue
$811,000,000.00
N/A
Revenue This Year
$5.35
N/A
Revenue Next Year
$3.88
N/A
P/E Ratio
$251.80
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.76
$0.13
52 Week High
$14.57
$49.95

Technical Indicators

Market Signals
Indicator
VREX
VOR
Relative Strength Index (RSI) 25.83 54.23
Support Level $11.43 $11.27
Resistance Level $11.94 $16.95
Average True Range (ATR) 0.41 1.17
MACD -0.19 0.05
Stochastic Oscillator 0.68 54.04

Price Performance

Historical Comparison
VREX
VOR

About VREX Varex Imaging Corporation

Varex Imaging Corp Designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, detectors, ionization chambers, high-voltage connectors, software, collimators, generators, exposure control devices, and heat exchangers.. The company operates through two segments: Medical, the key revenue driver, providing X-ray imaging components and accessories for healthcare applications, and Industrial, which provides Linatron X-ray accelerators, X-ray tubes, flat panel detectors, high-voltage connectors, and coolers for non-medical use. Geographically, it generates the majority of its revenue from Europe, the Middle East, and Africa (EMEA), with the rest coming from the Americas and Asia Pacific.

About VOR Vor Biopharma Inc.

Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.

Share on Social Networks: